BioSpace News Archive

Biotech Beach

PhaseBio Highlights Real-World Healthcare Cost and Bleeding Cost Data Featured at the International Society for Pharmacoeconomic and Outcomes Research (ISPOR) Virtual 2021 Conference

Study leveraging the IBM® MarketScan® claims database examined healthcare resource utilization including total healthcare costs and bleeding costs in patients initiating P2Y 12 inhibitors, FXa inhibitors or dabigatran Analyses revealed that patients receiving P2Y 12 inhibitors incurred total costs and bleeding-related costs similar to or greater than patients prescribed FXa inhibitors or dabigatran

May 20, 2021
·
7 min read
BioMidwest

Paragon 28® Inc., Expands its Novel Biologics Portfolio with Addition of Three Families of DBM

Introducing BEAST™ Injectable, BEAST PLUS™, and BEAST™ Osteobiologic Sponge for bone grafting applications in the foot and ankle.

May 20, 2021
·
1 min read